Much of the research in optimizing anticoagulant therapy for acute VTE has been carried out in patients without malignancies. Given the aggressive natural history of VTE in cancer patients ...

Clinicians should remain vigilant about VTE risk extending beyond the hospital ... et al "Hypercoagulation after hospital discharge in acute severe ulcerative colitis: A prospective study" Clin ...

Second, I will now begin offering this half-dose DOAC strategy to patients with cancer-associated VTE after they have completed their initial 6 months of anticoagulation therapy for an acute VTE ...

Investigators studied the prevalence and outcomes of venous thromboembolic events (VTEs) among hospitalized patients with and without CKD.

When you go to the hospital with a new blood clot (acute DVT), your doctor usually gives heparin at first. After heparin treatment, you'll need blood tests to monitor the dose. Low-molecular ...

A case presentation involving a patient with severe, symptomatic iliofemoral deep vein thrombosis and need for urgent ...

Deep vein thrombosis (DVT) is a significant health problem, leading to the hospital admission of over 250,000 Americans each year. Its most serious acute complication, namely pulmonary embolus ...